HUTCHMED's New aDrug Application for Tazemetostat in Relapsed or Refractory Follicular Lymphoma Granted Priority Review by China NMPA

HUTCHMED (China) Limited (“HUTCHMED”)  announces that the New Drug Application (“NDA”) for tazemetostat for the treatment of...

July 04, 2024 | Thursday | News
Vertex Pharmaceuticals' Vanza Triple Granted Priority Review by FDA with Target Action Date of January 2, 2025

Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...

July 03, 2024 | Wednesday | News
Hofseth BioCare ASA Transfers Eosinophil-Targeting Drug Candidate MA-022a to Subsidiary HBC Immunology Inc

Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research,  announces the decision to transfer its eosinoph...

July 02, 2024 | Tuesday | News
Regulatory Review Begins for Bavarian Nordic's Single-Dose Chikungunya Vaccine in EU and U.S.

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...

June 26, 2024 | Wednesday | News
dsm-firmenich Introduces CBtru®: Transforming CBD Drug Delivery

dsm-firmenich, innovators in nutrition, health, and beauty, has announced the launch of CBtru® – an advanced formulated cannabidiol (CBD) drug ...

June 25, 2024 | Tuesday | News
Bio-Rad Laboratories Launches New Anti-Idiotypic and Anti-MMAE Antibodies for Enhanced Bioanalytical Assays

  Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...

June 25, 2024 | Tuesday | News
BioNTech and DualityBio's ADC Candidate BNT324/DB-1311 Gains FDA Fast-Track Status for Prostate Cancer

The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...

June 25, 2024 | Tuesday | News
Japan Approves Takeda's LIVTENCITY® for Post-Transplant CMV Infection

Takeda announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) for post-transplant cy...

June 24, 2024 | Monday | News
Cresset Achieves SOC 2 Type 1 Compliance, Reinforcing Commitment to Data Security

    Developed by the American Institute of Certified Public Accountants (AICPA), a SOC 2 information security standard is a report that validat...

June 21, 2024 | Friday | News
AbbVie’s SKYRIZI® Gains FDA Approval for Moderate to Severe Ulcerative Colitis and Crohn's Disease Following Successful Phase 3 Trials

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...

June 20, 2024 | Thursday | News
Milestone Scientific Receives Regulatory Approval to Launch CompuFlo® Epidural System in Brazil

Milestone Scientific , a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has ...

June 19, 2024 | Wednesday | News
RevOpsis and Kemwell Partner to Accelerate Development of RO-104 for nAMD

Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...

June 18, 2024 | Tuesday | News
Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
Thermo Fisher Scientific's PPD Clinical Research Business Earns 13th Consecutive CRO Leadership Award

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug ...

June 17, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close